Hosted on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
BIOTRONIK has commenced its global pivotal trial assessing the LivIQ leadless pacemaker system, a next-generation single device solution intended for delivering atrioventricular (AV) synchrony through ...
International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging geography in the heart, for delivering electric signals that more closely ...
LAKE OSWEGO, Ore., July 6, 2023 /PRNewswire/ -- BIOTRONIK today announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronization ...
BERLIN, March 24, 2026 /PRNewswire/ -- BIOTRONIK today announced the initiation of its global pivotal study evaluating the LivIQ leadless pacemaker system. This next-generation single‑device solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results